TomoTherapy Sets IPO Terms

TomoTherapy Inc., a Madison, Wis.-based developer of cancer treatment systems that use on-board CT imaging and conformal radiation therapy, has set its proposed IPO terms to around 10.94 million common shares being offered at between $15 and $17 per share. It plans to trade on the Nasdaq under ticker symbol TTPY, with Merrill Lynch serving as lead underwriter. The company has raised around $79 million in VC funding since 1999, from firms like The Endeavors Group, Open Prairie Ventures, State of Wisconsin Investment Board, Advantage Capital Wisconsin Partners and Ascension Health Ventures.